Targeted Tablet Approved for ESR1 Breast Cancer

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/targeted-tablet-approved-esr1-breast-cancer-2026a10005xy?src=rss

Author :

Publish date : 2026-02-25 14:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Targeted Tablet Approved for ESR1 Breast Cancer

Trump Touched on Healthcare in State of the Union Speech: Here’s What He Said

Cream Cheese Recall; Nobel Winner Resigns Over Epstein Ties; Cadaver Fat in Surgery

Related Posts

Sperm swim more quickly in summer, study finds

Dupilumab Approved for Allergic Fungal Rhinosinusitis

Age, HIV, and Metabolic Syndrome Together Tied to Cognitive Impairment Risk

Single-Dose Dolutegravir Safe in Kids With HIV Receiving Preventive TB Treatment

NIH Agency to Scrub Words From Website; Epstein’s Genes; $2B WHO ‘Alternative’

Skin Infections Common in Border Camps

Sperm swim more quickly in summer, study finds

Dupilumab Approved for Allergic Fungal Rhinosinusitis

Age, HIV, and Metabolic Syndrome Together Tied to Cognitive Impairment Risk

Single-Dose Dolutegravir Safe in Kids With HIV Receiving Preventive TB Treatment

NIH Agency to Scrub Words From Website; Epstein’s Genes; $2B WHO ‘Alternative’

Skin Infections Common in Border Camps

Medical School Should Be Free, Billionaire Says

Penguins in Party Hats? Birthday Cards Cheer Families of Babies Treated for Botulism

Categories

Archives